BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward ...

In a recent Special Meeting held on Monday, Matinas BioPharma (NYSE:MTNB) Holdings, Inc. received shareholder approval on several significant proposals. The meeting, which was convened on April 4 ...

Shares of Matinas Biopharma Holdings, Inc. (NYSE:MTNB – Get Free Report) fell 6.6% during mid-day trading on Tuesday .The company traded as low as $0.53 and last traded at $0.56. 46,870 shares ...

Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American: MTNB), currently trading at $0.55 with a market capitalization of $2.79 million, disclosed in a recent SEC filing that Eric Ende ...

Short interest in Matinas BioPharma Holdings Inc (AMEX:MTNB) decreased during the last reporting period, falling from 291.99K to 232.41K. This put 4.69% of the company's publicly available shares ...

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery ...

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward ...

In a recent Special Meeting held on Monday, Matinas BioPharma (NYSE:MTNB) Holdings, Inc. received shareholder approval on several significant proposals. The meeting, which was convened on April 4, ...